×
ADVERTISEMENT

IBS

Harnessing AI to Improve GI Health

A small pilot study from Turkey showed that clinicians can use ML to tailor the diets of people with IBS, ...

MARCH 26, 2024

FDA Determines REMS for Alosetron No Longer Necessary

The FDA has determined Risk Evaluation and Mitigation Strategies for the irritable bowel syndrome drug alosetron ...

SEPTEMBER 26, 2023

Tips for Treating Challenge Cases of IBS-D

For patients in whom diarrhea affects quality of life, diet, pharmaceutical agents and behavioral therapy are ...

JUNE 22, 2023

Subcutaneous Infliximab And the FODMAP Diet

Although infliximab is one of the oldest therapies for IBD, first approved by the FDA for the treatment of ...

DECEMBER 14, 2022

OTC Intestinal Adsorbent Relieves IBS-D Symptoms

An over-the-counter intestinal adsorbent significantly improved a host of symptoms related to diarrhea-predominant ...

AUGUST 24, 2022

Load more